Website stats and analysis
adsense unsafe advertisement

Language: English
Keywords: Mesoblast, Biotechnology, Therapies, Melbourne, Australia
Layout: Text-based with some graphical elements
ColorStyle: White, Black, Orange
Overview: Mesoblast is a biotechnology company focused on developing innovative therapies for serious diseases. They are working on treatments for a range of conditions, including cancer, heart disease, and respiratory conditions. The company is based in Melbourne, Australia and has a global presence.

unsafe advertisement
2.48 Rating by Usitestat

mesoblast.com was registered 2 decades 7 months ago. It has a alexa rank of #1,486,657 in the world. It is a domain having .com extension. It is estimated worth of $ 960.00 and have a daily income of around $ 4.00. As no active threats were reported recently, mesoblast.com is SAFE to browse.

Traffic Report

Daily Unique Visitors: 590
Daily Pageviews: 1,180

Estimated Valuation

Income Per Day: $ 4.00
Estimated Worth: $ 960.00

Search Engine Indexes

Google Indexed Pages: Not Applicable
Yahoo Indexed Pages: Not Applicable
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable
Alexa BackLinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: Not Applicable
WOT Trustworthiness: Very Poor
WOT Privacy: Very Poor
WOT Child Safety: Very Poor

Website Ranks & Scores

Alexa Rank: 1,486,657
PageSpeed Score: 69 ON 100
Domain Authority: 49 ON 100
Bounce Rate: Not Applicable
Time On Site: Not Applicable

Web Server Information

Hosted IP Address:

104.17.178.5

Hosted Country:

United States US

Location Latitude:

37.7757

Location Longitude:

-122.395
unsafe advertisement

Traffic Classification

Total Traffic: No Data
Direct Traffic: No Data
Referral Traffic: No Data
Search Traffic: No Data
Social Traffic: No Data
Mail Traffic: No Data
Display Traffic: No Data

Search Engine Results For mesoblast.com

Home - Mesoblast Ltd

- http://www.mesoblast.com/

Mesoblast is committed to bringing to market innovative cellular medicines to treat serious and life-threatening diseases with significant, unmet medical needs.


Overview - Mesoblast Ltd

- https://mesoblast.com/company/overview


Mesoblast - Wikipedia

- https://en.wikipedia.org/wiki/Mesoblast

Mesoblast Limited is an Australian-based regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease and back pain. The...


Webcasts & Presentations | Mesoblast

- http://investorsmedia.mesoblast.com/webcasts-presentations/

The Investor Relations website contains information about Mesoblast's business for stockholders, potential investors, and financial analysts.


Mesoblast - MESO - Stock Price & News | The Motley Fool

- https://www.fool.com/quote/nasdaq/mesoblast/meso/

Real time Mesoblast (MESO) stock price quote, stock graph, news & analysis.


Mesoblast Receives Complete Response Letter From the FDA ...

- https://www.tmcnet.com/usubmit/-mesoblast-receives-complete-response-letter-from-fda-biologics-/2020/10/01/9230963.htm

Oct 01, 2020 · The archived webcast will be available on the Investor page of the Company’s website www.mesoblast.com. About Mesoblast Mesoblast Limited (Nasdaq:MESO; ASX:MSB)...


Mesoblast Limited (MESO) Stock Price, News, Quote ...

- https://finance.yahoo.com/quote/MESO

Find the latest Mesoblast Limited (MESO) stock quote, history, news and other vital information to help you with your stock trading and investing.


Mesoblast surges as COVID-19 treatment shows promise

- https://www.afr.com/companies/healthcare-and-fitness/mesoblast-s-covid-19-treatment-shows-positive-signs-20200424-p54muq

Apr 24, 2020 · Mesoblast chief medical officer Fred Grossman said there is a significant need to improve the dismal survival outcomes in COVID-19 patients who progress to ARDS...


Mesoblast Receives Complete Response Letter From the FDA ...

- https://markets.businessinsider.com/news/stocks/mesoblast-receives-complete-response-letter-from-the-fda-for-biologics-license-application-for-steroid-refractory-acute-graft-versus-host-disease-in-children-1029642425

Oct 02, 2020 · The archived webcast will be available on the Investor page of the Company’s website www.mesoblast.com About Mesoblast Mesoblast Limited (Nasdaq:MESO; ASX:MSB) is...


Mesoblast Receives Complete Response Letter From the FDA ...

- https://markets.businessinsider.com/news/stocks/mesoblast-receives-complete-response-letter-from-the-fda-for-biologics-license-application-for-steroid-refractory-acute-graft-versus-host-disease-in-children-1029642425

The archived webcast will be available on the Investor page of the Company’s website www.mesoblast.com About Mesoblast Mesoblast Limited (Nasdaq:MESO; ASX:MSB) is a world leader...


Mesoblast Limited | LinkedIn

- https://www.linkedin.com/company/mesoblast

Mesoblast (ASX:MSB; Nasdaq:MESO) is developing and commercializing allogeneic cellular medicines to treat serious and life-threatening inflammatory diseases with significant,...


Mesoblast | Edison

- https://www.edisongroup.com/company/mesoblast/1619/

Oct 29, 2020 · Mesoblast is an Australia-based biotechnology company developing adult stem-cell therapies based on its proprietary MPC and MSC platforms. Its lead programs are...


Mesoblast Receives Complete Response Letter From the FDA ...

- https://www.benzinga.com/pressreleases/20/10/g17748293/mesoblast-receives-complete-response-letter-from-the-fda-for-biologics-license-application-for-ste

E:[email protected]: Kristen Bothwell T: +1 917 613 5434 E:[email protected] Investors Schond Greenway T: +212 880 2060 E: [email protected]: Paul...


Mesoblast Receives Complete Response Letter From the FDA ...

- https://finance.yahoo.com/news/mesoblast-receives-complete-response-letter-232500557.html

E:[email protected]. Kristen Bothwell T: +1 917 613 5434 E:[email protected]. Investors Schond Greenway T: +212 880 2060 E: [email protected]. Paul...


Mesoblast Ltd ADR (MESO) Quote | Morningstar

- https://www.morningstar.com/stocks/XNAS/MESO/quote

Business Description. Mesoblast is a small cap biotech company with listings on both the ASX and the Nasdaq. The company has acquired the rights to develop and commercialize...


Mesoblast Provides Remestemcel-L Update and Quarterly ...

- https://markets.businessinsider.com/news/stocks/mesoblast-provides-remestemcel-l-update-and-quarterly-activity-report-1029449845

Jul 30, 2020 · E:[email protected] Kristen Bothwell T: +1 917 613 5434 E:[email protected] Investors Schond Greenway T: +212 880 2060 E:...


Mesoblast and Tasly Pharmaceutical Group Complete ...

- https://www.globenewswire.com/news-release/2018/10/12/1620435/0/en/Mesoblast-and-Tasly-Pharmaceutical-Group-Complete-Transaction-for-Strategic-Cardiovascular-Partnership-in-China.html

Oct 12, 2018 · Mesoblast has facilities in Melbourne, New York, Singapore and Texas and is listed on the Australian Securities Exchange (MSB) and on the Nasdaq (MESO)....


Mesoblast (@Mesoblast) | Stocktwits

- https://stocktwits.com/Mesoblast

The latest messages and market ideas from Mesoblast (@Mesoblast) on Stocktwits. Mesoblast Limited (ASX:MSB; USOTC:MBLTY) is developing novel biotherapeutics derived from its...


Mesoblast Receives Ethics Approval to Treat COVID-19 ...

- https://www.globenewswire.com/news-release/2020/09/02/2087511/0/en/Mesoblast-Receives-Ethics-Approval-to-Treat-COVID-19-Patients-in-Australia.html

Sep 02, 2020 · Media Julie Meldrum T: +61 3 9639 6036 E:[email protected] Kristen Bothwell T: +1 917 613 5434 E:[email protected] Investors Schond Greenway T:...


Mesoblast - Crunchbase Company Profile & Funding

- https://www.crunchbase.com/organization/mesoblast

Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's patented Mesenchymal Precursor Cell (MPC) technology is being developed...


MESO - Mesoblast Limited • BioPharmCatalyst

- https://www.biopharmcatalyst.com/company/meso

The archived webcast will be available on the Investor page of the Company's website www.mesoblast.com About Mesoblast Mesoblast Limited (NASDAQ: MESO , ASX:MSB))) is a world...

Page Resources Breakdown

Homepage Links Analysis

Home - Mesoblast Ltd
Learn more about Mesoblast's adult stem cell research and the potential to cure human disease.

Website Inpage Analysis

H1 Headings: 4 H2 Headings: Not Applicable
H3 Headings: Not Applicable H4 Headings: Not Applicable
H5 Headings: Not Applicable H6 Headings: Not Applicable
Total IFRAMEs: Not Applicable Total Images: 5
Google Adsense: Not Applicable Google Analytics: UA-40783513-1

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Mon, 08 Jul 2019 04:22:13 GMT
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
X-Content-Type-Options: nosniff
X-Powered-By: PHP/7.2.15
Expires: Wed, 17 Aug 2005 00:00:00 GMT
Last-Modified: Mon, 08 Jul 2019 04:23:19 GMT
Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0
Pragma: no-cache
Server: cloudflare
CF-RAY: 4f2f469bce187cd0-MUC
Content-Encoding: gzip

Domain Information

Domain Registrar: TPP Domains Pty Ltd. dba TPP Internet
Registration Date: 2004-08-11 2 decades 7 months 2 weeks ago
Last Modified: 2018-06-25 6 years 9 months 5 days ago

DNS Record Analysis

Host Type TTL Extra
mesoblast.com A 287 IP: 104.17.178.5
mesoblast.com A 287 IP: 104.17.177.5
mesoblast.com NS 86400 Target: josh.ns.cloudflare.com
mesoblast.com NS 86400 Target: mona.ns.cloudflare.com
mesoblast.com SOA 3600 MNAME: josh.ns.cloudflare.com
RNAME: dns.cloudflare.com
Serial: 2031166946
Refresh: 10000
Retry: 2400
Expire: 604800
mesoblast.com MX 300 Priority: 10
Target: mx1-us1.ppe-hosted.com
mesoblast.com MX 300 Priority: 20
Target: mx2-us1.ppe-hosted.com
mesoblast.com TXT 300 TXT:
yXyh9JEPhZwSoRGdEaBgONVwQFDjfSnQKX9ns/nx
Fk6T3D1rUVStLnsoO1F68NfI4QTMcNCDOG7xENPg
yw7IQQ==
mesoblast.com TXT 300 TXT: ppe-5b0284deda2556fcb49c
mesoblast.com TXT 300 TXT: v=spf1 +a +mx +ip4:43.245.71.6
+ip4:27.131.109.2 +ip4:27.131.109.3
+ip4:168.75.166.211
a:dispatch-us.ppe-hosted.com
include:spf.protection.outlook.com ~all
mesoblast.com TXT 300 TXT:
MS=60910A88353E0DC5F166F195995A543F8A51A
929
mesoblast.com TXT 300 TXT: MS=ms54571174
mesoblast.com AAAA 287 IPV6: 2606:4700::6811:b205
mesoblast.com AAAA 287 IPV6: 2606:4700::6811:b105

Full WHOIS Lookup

Domain Name: MESOBLAST.COM
Registry Domain ID:
126953624_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.tppinternet.com
Registrar URL:
http://www.melbourneit.com.au
Updated Date:
2018-06-25T01:38:12Z
Creation Date:
2004-08-11T04:39:28Z
Registry Expiry Date:
2019-08-11T04:39:28Z
Registrar: TPP Domains Pty Ltd. dba TPP
Internet
Registrar IANA ID: 972
Registrar Abuse Contact
Email:
Registrar Abuse Contact Phone:
Domain Status: ok
https://icann.org/epp#ok
Name Server:
JOSH.NS.CLOUDFLARE.COM
Name Server:
MONA.NS.CLOUDFLARE.COM
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2019-07-08T04:22:17Z

Similarly Ranked Websites

RockPeaks | Music Video Community

- rockpeaks.com

The open database of music video, film and television. Browse and stream clips, match personal media, contribute missing metadata.

1,486,670   $ 960.00

Optima Sonoran Village | Apartments in Scottsdale, AZ

- optimasonoranvillage.com

Check for available units at Optima Sonoran Village in Scottsdale, AZ. View floor plans, photos, and community amenities. Make Optima Sonoran Village your new home.

1,486,671   $ 960.00

リネット LINNET :Linen cotton Fabrics & mercerie Garden*Garden@LINNET...

- lin-net.com

Welcome to LINNET, Kyoto, Japan/ 京都の LINNET のトップページです。LINNET is a company introducing the original linen fabrics and products. Also we carry Linen Yarns, Buttons , Original...

1,486,672   $ 960.00

Plantar Fasciitis Resource - Plantar Fasciitis Resource

- plantarfasciitisresource.com

Plantar Fasciitis Resource

1,486,687   $ 960.00

m4n.nl | Jouw startpagina

- m4n.nl

Jouw startpagina

1,486,688   $ 960.00
unsafe advertisement